PDT Partners’s Chembio diagnostics, Inc. CEMI Stock Holding History

PDT Partners’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-22,978	Closed	-$81K	–	1018
2021 Q1	$81K	Buy	+22,978	New	+$128K	0.01%	746

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PDT Partners's CEMI Position: Q2 2021 in Review

PDT Partners sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 22,978 shares — an estimated $81K sold.

PDT Partners first reported a position in CEMI in Q1 2021 and held it in 1 quarter. The position peaked at $81K in Q1 2021. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

PDT Partners reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
PDT Partners sold 22,978 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $81K.
PDT Partners first reported a position in Chembio diagnostics, Inc. in Q1 2021 and held it in 1 quarter.
PDT Partners's Chembio diagnostics, Inc. position peaked at $81K in Q1 2021.
60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on PDT Partners's 13F filing for Q2 2021, filed 16 Aug 2021.